Takeda Kept Generic Drug Off Shelves For 6 Years, Suit Says
IP Law 360
AUGUST 3, 2021
Takeda Pharmaceutical Co. was hit with a proposed class action Tuesday in Massachusetts federal court by a drug company who claims the pharmaceutical giant paid a competitor to keep a generic anti-constipation drug off the market for six years to preserve Takeda's monopoly.
52 
Let's personalize your content